{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:27:11Z","timestamp":1785353231121,"version":"3.55.0"},"reference-count":48,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JND"],"published-print":{"date-parts":[[2017,2,28]]},"DOI":"10.3233\/jnd-160184","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T11:54:23Z","timestamp":1488282863000},"page":"77-87","source":"Crossref","is-referenced-by-count":13,"title":["Histopathologic and Biochemical Evidence for Mitochondrial Disease Among 279 Patients with Severe Statin Myopathy"],"prefix":"10.1177","volume":"4","author":[{"given":"Tieying","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reid R.","family":"Heffner","sequence":"additional","affiliation":[{"name":"Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgirene D.","family":"Vladutiu","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics, Neurology, and Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, NY, USA"},{"name":"Kaleida Health Laboratories, Buffalo, NY, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"2","key":"10.3233\/JND-160184_ref1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1042\/CS20150027","article-title":"Cellular and molecular mechanisms of statins: An update on pleiotropic effects","volume":"129","author":"Satoh","year":"2015","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"10.3233\/JND-160184_ref2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trsl.2015.06.017","article-title":"Targeting inflammation in metabolic syndrome","volume":"167","author":"Welty","year":"2016","journal-title":"Transl Res"},{"key":"10.3233\/JND-160184_ref3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2147\/DDDT.S14934","article-title":"Primary prevention of coronary heart disease: Integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey","volume":"5","author":"Kones","year":"2011","journal-title":"Drug Des Devel Ther"},{"issue":"17","key":"10.3233\/JND-160184_ref4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/eurheartj\/ehv043","article-title":"Statin-associated muscle symptoms: Impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management","volume":"36","author":"Stroes","year":"2015","journal-title":"Eur Heart J"},{"issue":"3","key":"10.3233\/JND-160184_ref5","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bcp.12360","article-title":"Mechanisms and assessment of statin-related muscular adverse effects","volume":"78","author":"Mosshammer","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.3233\/JND-160184_ref6","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care settings: A cohort study","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.3233\/JND-160184_ref7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/mus.22205","article-title":"Prevalence and risk factors of muscle complications secondary to statins","volume":"44","author":"El-Salem","year":"2011","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.3233\/JND-160184_ref8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjmed.2011.08.007","article-title":"Statin use and musculoskeletal pain among adults with and without arthritis","volume":"125","author":"Buettner","year":"2012","journal-title":"Am J Med"},{"issue":"6","key":"10.3233\/JND-160184_ref9","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2013the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"10.3233\/JND-160184_ref10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ahj.2014.03.019","article-title":"A systematic review of statin-induced muscle problems in clinical trials","volume":"168","author":"Ganga","year":"2014","journal-title":"Am Heart J"},{"issue":"2","key":"10.3233\/JND-160184_ref11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","article-title":"Genetic risk factors associated with lipid-lowering drug-induced myopathies","volume":"34","author":"Vladutiu","year":"2006","journal-title":"Muscle Nerve"},{"issue":"1-2","key":"10.3233\/JND-160184_ref12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ymgme.2011.07.001","article-title":"Genetic risk for malignant hyperthermia in non-anesthesia-induced myopathies","volume":"104","author":"Vladutiu","year":"2011","journal-title":"Mol Genet Metab"},{"issue":"8","key":"10.3233\/JND-160184_ref13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy\u2013a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"10.3233\/JND-160184_ref14","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/clpt.2012.57","article-title":"The clinical pharmacogenomics implementation consortium: CPIC guideline for SLCO1B1 and simvastatin-induced myopathy","volume":"92","author":"Wilke","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.3233\/JND-160184_ref15","first-page":"264","article-title":"Inborn errors of muscle metabolism implicated in risk for statin-induced myopathy","volume":"111","author":"Vladutiu","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"12","key":"10.3233\/JND-160184_ref16","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.15252\/emmm.201505079","article-title":"Mitochondrial disease in adults: What\u2019s old and what\u2019s new?","volume":"7","author":"Chinnery","year":"2015","journal-title":"EMBO Mol Med"},{"issue":"Suppl 2","key":"10.3233\/JND-160184_ref17","doi-asserted-by":"crossref","first-page":"S325","DOI":"10.2337\/dcS13-2038","article-title":"Intolerance to statins: Mechanisms and management","volume":"36","author":"Bitzur","year":"2013","journal-title":"Diabetes Care"},{"issue":"11","key":"10.3233\/JND-160184_ref18","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1093\/eurheartj\/ehr224","article-title":"Opposite effects of statins on mitochondria of cardiac and skeletal muscles: A \u2018mitohormesis\u2019 mechanism involving reactive oxygen species and PGC-1","volume":"33","author":"Bouitbir","year":"2012","journal-title":"Eur Heart J"},{"issue":"2","key":"10.3233\/JND-160184_ref19","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/mus.24722","article-title":"Skeletal muscle ultrastructure and function in statin-tolerant individuals","volume":"53","author":"Rengo","year":"2016","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.3233\/JND-160184_ref20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ana.410210607","article-title":"Progressive cytochrome c oxidase deficiency in a case of Kearns-Sayre syndrome: Morphological, immunological, and biochemical studies in muscle biopsies and autopsy tissues","volume":"21","author":"Bresolin","year":"1987","journal-title":"Ann Neurol"},{"issue":"12","key":"10.3233\/JND-160184_ref21","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.5858\/2000-124-1755-SDD","article-title":"Succinate dehydrogenase deficiency","volume":"124","author":"Vladutiu","year":"2000","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.3233\/JND-160184_ref22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005072-199405000-00004","article-title":"Concomitant branching enzyme and phosphorylase deficiencies. An unusual glycogenosis with extensive neuronal polyglucosan storage","volume":"53","author":"Herrick","year":"1994","journal-title":"J Neuropathol Exp Neurol"},{"issue":"10","key":"10.3233\/JND-160184_ref23","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.autrev.2016.07.023","article-title":"Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study","volume":"15","author":"Musset","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.3233\/JND-160184_ref24","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.3233\/JND-160184_ref25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: Statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.3233\/JND-160184_ref26","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/CIRCULATIONAHA.112.136101","article-title":"Effect of statins on skeletal muscle function","volume":"127","author":"Parker","year":"2013","journal-title":"Circulation"},{"key":"10.3233\/JND-160184_ref27","volume-title":"GeneReviews(R) [Internet]","author":"Chinnery","year":"2000"},{"issue":"20","key":"10.3233\/JND-160184_ref28","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.jacc.2016.02.071","article-title":"Statin-associated side effects","volume":"67","author":"Thompson","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.3233\/JND-160184_ref29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14740338.2012.630659","article-title":"Is there clinical benefit to routine enzyme testing of patients on statins?","volume":"11","author":"Elhayany","year":"2012","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"10.3233\/JND-160184_ref30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijcard.2011.07.048","article-title":"Managing the underestimated risk of statin-associated myopathy","volume":"159","author":"Rallidis","year":"2012","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.3233\/JND-160184_ref31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pcl.2016.08.011","article-title":"Presentation and diagnostic evaluation of mitochondrial disease","volume":"64","author":"Dimmock","year":"2017","journal-title":"Pediatr Clin North Am"},{"issue":"19-20","key":"10.3233\/JND-160184_ref32","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00018-006-6235-z","article-title":"Toxicity of statins on rat skeletal muscle mitochondria","volume":"63","author":"Kaufmann","year":"2006","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"10.3233\/JND-160184_ref33","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/sj.clpt.6100124","article-title":"Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin","volume":"81","author":"Schick","year":"2007","journal-title":"Clin Pharmacol Ther"},{"issue":"1-2","key":"10.3233\/JND-160184_ref34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jns.2012.12.023","article-title":"Decreased skeletal muscle mitochondrial DNA in patients with statin-induced myopathy","volume":"325","author":"Stringer","year":"2013","journal-title":"J Neurol Sci"},{"issue":"5","key":"10.3233\/JND-160184_ref35","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/(SICI)1096-8628(19980605)77:5<395::AID-AJMG8>3.0.CO;2-M","article-title":"Yield of mtDNA mutation analysis in 2,000 patients","volume":"77","author":"Liang","year":"1998","journal-title":"Am J Med Genet"},{"issue":"7","key":"10.3233\/JND-160184_ref36","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMra1515161","article-title":"Statin-associated autoimmune myopathy","volume":"374","author":"Mammen","year":"2016","journal-title":"N Engl J Med"},{"issue":"1","key":"10.3233\/JND-160184_ref37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/path.2018","article-title":"Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia","volume":"210","author":"Draeger","year":"2006","journal-title":"J Pathol"},{"issue":"7","key":"10.3233\/JND-160184_ref38","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/eci.12461","article-title":"The role of mitochondria in statin-induced myopathy","volume":"45","author":"Apostolopoulou","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"23","key":"10.3233\/JND-160184_ref39","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2007.02.049","article-title":"The role of coenzyme Q10 in statin-associated myopathy: A systematic review","volume":"49","author":"Marcoff","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.3233\/JND-160184_ref40","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.atherosclerosis.2014.12.016","article-title":"A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy","volume":"238","author":"Taylor","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.3233\/JND-160184_ref41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/14017431.2012.756119","article-title":"No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy","volume":"47","author":"Bogsrud","year":"2013","journal-title":"Scand Cardiovasc J"},{"issue":"6","key":"10.3233\/JND-160184_ref42","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/MOL.0b013e3283168ecd","article-title":"Effects of ubiquinone (coenzyme Q10) on myopathy in statin users","volume":"19","author":"Schaars","year":"2008","journal-title":"Curr Opin Lipidol"},{"issue":"Suppl","key":"10.3233\/JND-160184_ref43","doi-asserted-by":"crossref","first-page":"s187","DOI":"10.1016\/0098-2997(94)90028-0","article-title":"Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors","volume":"15","author":"Bargossi","year":"1994","journal-title":"Mol Aspects Med"},{"issue":"22","key":"10.3233\/JND-160184_ref44","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1073\/pnas.87.22.8931","article-title":"Lovastatin decreases coenzyme Q levels in humans","volume":"87","author":"Folkers","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.3233\/JND-160184_ref45","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjcard.2004.07.121","article-title":"Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction","volume":"94","author":"Silver","year":"2004","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.3233\/JND-160184_ref46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mayocp.2014.08.021","article-title":"Effects of coenzyme Q10 on statin-induced myopathy: A meta-analysis of randomized controlled trials","volume":"90","author":"Banach","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.3233\/JND-160184_ref47","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.jacc.2013.02.074","article-title":"Simvastatin impairs exercise training adaptations","volume":"62","author":"Mikus","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.3233\/JND-160184_ref48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/mus.21847","article-title":"Evaluation of skeletal muscle during calf exercise by 31-phosphorus magnetic resonance spectroscopy in patients on statin medications","volume":"43","author":"Wu","year":"2011","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neuromuscular Diseases"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JND-160184","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T23:53:19Z","timestamp":1777506799000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JND-160184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,28]]},"references-count":48,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jnd-160184","relation":{},"ISSN":["2214-3599","2214-3602"],"issn-type":[{"value":"2214-3599","type":"print"},{"value":"2214-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,28]]}}}